310 related articles for article (PubMed ID: 23455986)
1. Epidemiology, co-morbidities, and medication use of patients with Alzheimer's disease or vascular dementia in the UK.
Imfeld P; Brauchli Pernus YB; Jick SS; Meier CR
J Alzheimers Dis; 2013; 35(3):565-73. PubMed ID: 23455986
[TBL] [Abstract][Full Text] [Related]
2. Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis.
Imfeld P; Bodmer M; Schuerch M; Jick SS; Meier CR
Epilepsia; 2013 Apr; 54(4):700-7. PubMed ID: 23215680
[TBL] [Abstract][Full Text] [Related]
3. Associations of anti-hypertensive treatments with Alzheimer's disease, vascular dementia, and other dementias.
Davies NM; Kehoe PG; Ben-Shlomo Y; Martin RM
J Alzheimers Dis; 2011; 26(4):699-708. PubMed ID: 21709373
[TBL] [Abstract][Full Text] [Related]
4. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
Passmore AP; Bayer AJ; Steinhagen-Thiessen E
J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
[TBL] [Abstract][Full Text] [Related]
5. Determinants of vascular dementia in the Cardiovascular Health Cognition Study.
Kuller LH; Lopez OL; Jagust WJ; Becker JT; DeKosky ST; Lyketsos C; Kawas C; Breitner JC; Fitzpatrick A; Dulberg C
Neurology; 2005 May; 64(9):1548-52. PubMed ID: 15883315
[TBL] [Abstract][Full Text] [Related]
6. Excess Costs Associated with Possible Misdiagnosis of Alzheimer's Disease Among Patients with Vascular Dementia in a UK CPRD Population.
Happich M; Kirson NY; Desai U; King S; Birnbaum HG; Reed C; Belger M; Lenox-Smith A; Price D
J Alzheimers Dis; 2016 May; 53(1):171-83. PubMed ID: 27163798
[TBL] [Abstract][Full Text] [Related]
7. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study.
Lopez OL; Kuller LH; Becker JT; Jagust WJ; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Kawas C; Carlson M
Neurology; 2005 May; 64(9):1539-47. PubMed ID: 15883314
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
Allan LM; Ballard CG; Burn DJ; Kenny RA
J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
[TBL] [Abstract][Full Text] [Related]
9. Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study.
Hayden KM; Zandi PP; Lyketsos CG; Khachaturian AS; Bastian LA; Charoonruk G; Tschanz JT; Norton MC; Pieper CF; Munger RG; Breitner JC; Welsh-Bohmer KA;
Alzheimer Dis Assoc Disord; 2006; 20(2):93-100. PubMed ID: 16772744
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trial.
Ihl R; Tribanek M; Bachinskaya N;
Pharmacopsychiatry; 2012 Mar; 45(2):41-6. PubMed ID: 22086747
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerosis, Hypertension, and Diabetes in Alzheimer's Disease, Vascular Dementia, and Mixed Dementia: Prevalence and Presentation.
Javanshiri K; Waldö ML; Friberg N; Sjövall F; Wickerström K; Haglund M; Englund E
J Alzheimers Dis; 2018; 65(4):1247-1258. PubMed ID: 30149459
[TBL] [Abstract][Full Text] [Related]
12. Incidence and subtypes of dementia in three elderly populations of central Spain.
Bermejo-Pareja F; Benito-León J; Vega S; Medrano MJ; Román GC;
J Neurol Sci; 2008 Jan; 264(1-2):63-72. PubMed ID: 17727890
[TBL] [Abstract][Full Text] [Related]
13. Orthostatic hypotension and low blood pressure in organic dementia: a study of prevalence and related clinical characteristics.
Passant U; Warkentin S; Gustafson L
Int J Geriatr Psychiatry; 1997 Mar; 12(3):395-403. PubMed ID: 9152727
[TBL] [Abstract][Full Text] [Related]
14. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?
Kim JM; Lyons D; Shin IS; Yoon JS
Hum Psychopharmacol; 2003 Apr; 18(3):215-20. PubMed ID: 12672174
[TBL] [Abstract][Full Text] [Related]
15. Proton Pump Inhibitor Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis.
Imfeld P; Bodmer M; Jick SS; Meier CR
Drug Saf; 2018 Dec; 41(12):1387-1396. PubMed ID: 30146658
[TBL] [Abstract][Full Text] [Related]
16. Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study.
Di Carlo A; Baldereschi M; Amaducci L; Lepore V; Bracco L; Maggi S; Bonaiuto S; Perissinotto E; Scarlato G; Farchi G; Inzitari D;
J Am Geriatr Soc; 2002 Jan; 50(1):41-8. PubMed ID: 12028245
[TBL] [Abstract][Full Text] [Related]
17. Midlife physical activity is associated with lower incidence of vascular dementia but not Alzheimer's disease.
Hansson O; Svensson M; Gustavsson AM; Andersson E; Yang Y; Nägga K; Hållmarker U; James S; Deierborg T
Alzheimers Res Ther; 2019 Oct; 11(1):87. PubMed ID: 31630687
[TBL] [Abstract][Full Text] [Related]
18. Socio-demographic variation of dementia subtypes in china: Methodology and results of a prevalence study in Beijing, Chengdu, Shanghai, and Xian.
Zhang ZX; Zahner GE; Román GC; Liu XH; Wu CB; Hong Z; Hong X; Tang MN; Zhou B; Qu QM; Zhang XJ; Li H
Neuroepidemiology; 2006; 27(4):177-87. PubMed ID: 17035714
[TBL] [Abstract][Full Text] [Related]
19. Incidence and etiology of dementia in a large elderly Italian population.
Ravaglia G; Forti P; Maioli F; Martelli M; Servadei L; Brunetti N; Dalmonte E; Bianchin M; Mariani E
Neurology; 2005 May; 64(9):1525-30. PubMed ID: 15883312
[TBL] [Abstract][Full Text] [Related]
20. Comorbid Medical Conditions in Vascular Dementia: A Matched Case-Control Study.
Habeych ME; Castilla-Puentes R
J Nerv Ment Dis; 2015 Aug; 203(8):604-8. PubMed ID: 26230648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
